Mission BioCapital logo

Mission BioCapital

Crunchbase
Pitchbook
Crunchbase

Deals on record

4

Common Fundraising Type

Seed

SiteOne Therapeutics logo
SiteOne Therapeutics

Biopharmaceutical

Novo Holdings logo
OrbiMed logo
Mission BioCapital logo
Wellington Management logo
BSQUARED Capital logo

SiteOne Therapeutics is a biopharmaceutical company developing selective, small molecule ion channel modulators for treating sensory hyperexcitability disorders like pain and chronic cough.

Series C
$100M
12/18/2024
Article
Alessa Therapeutics logo
Alessa Therapeutics

Drug development

Mission BioCapital logo
Johnson & Johnson logo

Alessa Therapeutics develops localized drug delivery systems for early cancer treatment, focusing on minimizing systemic side effects.

Seed
$15M
12/13/2024
Article
Nuvig Therapeutics logo
Nuvig Therapeutics

Biotechnology

Sanofi Ventures logo
Blue Owl Healthcare Opportunities logo
Norwest Venture Partners logo
Novo Holdings logo
Mission BioCapital logo
LOTTE Holdings logo
Leaps by Bayer logo
Global BioAccess Fund logo

Nuvig Therapeutics is a biotechnology company developing treatments for autoimmune diseases that do not rely on immunosuppression.

Series B
$161M
12/05/2024
Article
Integrated Biosciences logo
Integrated Biosciences

Synthetic biology

Integrated Biosciences uses synthetic biology and machine learning to develop therapeutics for age-related diseases.

Seed
$17.2M
10/03/2024
Article